A Multi-omics and Machine Learning Framework Identifies Plasma SBDS as a Causal Biomarker and Therapeutic Target in Primary Sclerosing Cholangitis

Read full text Summarise with VIRAT
Authors: Pengfei Cheng, 强远明, Yibo Sun, Binwei Duan, Yabo Ouyang, Guangming Li
Cited by: 0
References: 48

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and Aims: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease. Its molecular etiology remains poorly defined, hindering the development of mechanism-based diagnostics and therapies. Therefore, this study aimed to identify key molecular drivers and causal biomarkers of PSC by integrating transcriptomics, machine learning, and genetic causal inference. Methods: We deployed a computational framework combining transcriptomics, network biology, machine learning, and genetic causal inference. Peripheral blood transcriptomes from PSC patients and controls were analyzed to identify disease-associated modules. Candidate genes were refined via protein-protein interaction networks and a multi-algorithm machine learning screen. Causal inference was performed using two-sample Mendelian randomization, integrating plasma protein quantitative trait loci with PSC genome-wide association study summary statistics. Results: = 0.001). Sensitivity analyses supported the validity of the Mendelian randomization assumptions. Conclusions: Our study establishes disrupted ribosome homeostasis as a causal pathway in PSC and nominates plasma SBDS as a high-confidence diagnostic biomarker and therapeutic target. The integrative framework provides a generalizable strategy for discovering causal biomarkers in complex diseases.

Fields of Study & Subjects

Liver Diseases and Immunity Bioinformatics and Genomic Networks Drug-Induced Hepatotoxicity and Protection

Publication details

Journal / source
Journal of Clinical and Translational Hepatology
Volume
000
Issue
000
Pages
000–000
Publication date
20 March 2026
Language
EN